Expert Q&A: Device Innovation in Kidney Failure (ESRD/AKI)

This Signals audio overview gives you the highlights from our Expert Q&A on device innovation so you can listen while you work or on the go.¹

Summary

This series of expert interviews examines the current state of devices used to treat End-Stage Kidney Disease (ESKD) and Acute Kidney Injury (AKI). The article brings together six experts from different backgrounds in the field who discuss the current state of ESKD devices, the challenges facing their adoption, and recommendations for overcoming these challenges. The experts also discuss regulatory pathways and emerging trends that are exciting for the future of ESKD care. The article includes specific examples of new devices and their potential to improve the lives of ESKD patients.

Experts

• John E. Milad, Former Co-Founder & CEO at Quanta

• Michael Serle, Clinical Director at Mozarc Medical

• Dr. Cynthia Silva, VP Clinical Affairs at Outset

• Alex Hassan, Head of Product at Mendaera

• Eric Schlorff, CEO at SeaStar Medical

• David Narrow, CEO at Sonavex

Connect & Learn

Thank you for listening! Stay tuned for more Signals audio overviews, and join the conversation in the comments. Visit the Kidneyverse page to explore the top ideas, innovations, and investments shaping the future of kidney health.

---

Keep Exploring

Expert Q&A: Bringing New Devices To Market In Kidney Failure (ESKD)

Dialysis Decade: How Devices Get To Market & (Re)Moving The Needle on Access

Kidney Capital: Who, When & What Gets Funded In Kidney Care, Part 1

Kidney Capital: Who, When & What Gets Funded In Kidney Care, Part 2

Signals Brief: Home Dialysis Bill & FDA AR/VR Home Care Hub

"If it looks like a bubble, it may pop like one, too."

Remote Patient Monitoring in Kidney Care

10 Reasons for Optimism from Kidney Week 2023

---

Made Possible By

Signals is made possible with the generous support of our sponsors. We are grateful to partner with organizations committed to advancing kidney care and innovation: Roivios, 3iveLabs, Dialysis Education Services, and IKONA.

Become a sponsor 📣: We're accepting applications from mission-aligned companies looking to get in front of 12,000+ monthly readers across the Kidneyverse— clinicians, patients, industry leaders, researchers, policymakers, and investors.

Kidneyverse Careers Job Board 💼: Explore top job opportunities across kidney care, from startups to established industry players. Whether you're hiring or looking for your next move, Kidneyverse Careers is the place to connect with top talent and cutting-edge companies.

Submit News & Tips to the Signals Inbox 📬: Got a story, tip, or update that should be on our radar? Send it our way through the Signals Inbox. Your contributions help shape the conversation and keep the community informed on the latest developments.

Join the waitlist for our private chat groups, real-time data and in-person meetups. 🔐 We continue to hear feedback from dozens of you who want access to more data, more expert perspectives, and more ways to connect with one another. We're planning to accept our first limited group of members in early 2025, please fill out this form to join the waitlist.

Cover image: In 1943, Willem Kolff developed the first crude artificial kidney. Working with wooden drums and laundry tubs, Kolff built an apparatus that drew the patient’s blood, cleansed it of impurities, and then pumped it back into the patient.

###

1. This post is powered by Google’s NotebookLM. Learn more about audio overviews here.